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Abstract
Dipyrone (Dp) delays gastric emptying (GE) in rats. There is no
information about whether 4-aminoantipyrine (AA), one of its me-
tabolites, has the same effect. The objectives of the present study were
to assess the effects of AA and Dp on GE when administered intrave-
nously (iv) and intracerebroventricularly (icv) (240 µmol/kg and 4
µmol/animal, respectively) and on gastric compliance when adminis-
tered iv (240 µmol/kg). GE was determined in male Wistar rats
weighing 250-300 g (5-10 per group) after icv or iv injection of the
drug by measuring percent gastric retention (GR) of a saline meal
labeled with phenol red 10 min after administration by gavage. Gastric
compliance was estimated in anesthetized rats (10-11 per group), with
the construction of volume-pressure curves during intragastric infu-
sion of a saline meal. Compliance was significantly greater in animals
receiving Dp (mean ± SEM = 0.26 ± 0.009 mL/mmHg) and AA (0.24
± 0.012 mL/mmHg) than in controls (0.19 ± 0.009 mL/mmHg). AA
and Dp administered iv significantly increased GR (64.4 ± 2.5 and
54.3 ± 3.8%, respectively) compared to control (34 ± 2.2%), a
phenomenon observed only with Dp after icv administration. Subdia-
phragmatic vagotomy reduced the effect of AA (GR = 31.4 ± 1.5%)
compared to sham-treated animals. Baclofen, a GABAB receptor
agonist, administered icv significantly reduced the effect of AA (GR =
28.1 ± 1.3%). We conclude that Dp and AA increased gastric compli-
ance and AA delayed GE, with the participation of the vagus nerve,
through a pathway that does not involve a direct action of the drug on
the central nervous system.
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Introduction
Dipyrone (Dp), a phenylpyrazolone de-
rivative, administered intravenously (iv) and
intracerebroventricularly (icv) to rats, delays
the gastric emptying (GE) of a liquid meal.
When the drug was administered iv the phe-
nomenon was abolished by vagotomy and
by electrolytic lesion of the paraventricular
nucleus of the hypothalamus (1). Further-
more, it was demonstrated that this effect is
blocked by icv injection of baclofen (bac), a
GABAB receptor agonist (2).
GE is the process of gastric content trans-
fer to the small intestine caused by the coor-
dinated motor activity of the stomach, py-
lorus and duodenum (3). In situations in
which there is an alteration of GE, the par-
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ticipation of the stomach in the process can
be inferred by the in vivo determination of
volume and of gastric compliance as indica-
tors of gastric tonus (4). Gastric tonus re-
flects variations in the tonic contractions of
the proximal area of the stomach, which is
responsible for accommodation of the food
bolus. The tonus of this region is the result of
the balance of stimulatory (increasing) and
inhibitory (reducing) activities, with regula-
tion mostly occurring via the vagus nerve. In
general, the reduction of tonus is accompa-
nied by a slower GE of fluid (5). On the other
hand, the mechanical increase of gastric to-
nus by fundoplication in rats was accompa-
nied by an increased liquid GE (4). It is
possible that the delayed GE determined by
Dp is due to a reduction of gastric tonus.
Dp (sodium salt of antipyrinyl-methy-
laminomethane-sufonic acid) is a pro-drug
that is rapidly hydrolyzed by the gastric
juice when administered by the oral route,
forming 4-methylaminoantipyrine and be-
ing absorbed in this form (6,7). 4-Methyl-
aminoantipyrine is directly demethylated,
mostly in the liver, to 4-aminoantipyrine
(AA), with the later generation of other me-
tabolites. Cytochrome P450 metabolic isoen-
zymes participate in this process (7,8). The
pharmacological properties of Dp are attrib-
uted to its active metabolites 4-methylami-
noantipyrine and AA (6,7).
There are no literature reports about the
effect of Dp metabolites on GE although it
has been demonstrated that phenylpyrazo-
lone derivatives induce delayed GE (9,10).
In a previous study by our group, we demon-
strated that the iv administration of AA re-
duces the GE of liquid in rats (11).
On this basis, the objectives of the present
study carried out on rats were: 1) to compare
the effect of Dp and AA administered iv and
icv on GE, 2) to assess the iv effect of the two
drugs on the stomach compliance of anesthe-
tized rats, 3) to determine the effect of iv
administration of AA on GE in terms of dose-
response and time-response, and 4) to assess
the participation of the vagus nerve and of
GABAB receptors of the central nervous sys-
tem (CNS) in the effect of iv administration of
AA on GE.
Material and Methods
Male Wistar rats weighing 250-300 g
were used. The experimental protocols ap-
plied in the present study obeyed the recom-
mendations of the Brazilian College of Ani-
mal Experimentation (COBEA). Before be-
ing submitted to the surgical procedures for
vagotomy or for the implantation of a can-
nula into the lateral ventricle of the brain, the
animals were sedated with an ip injection of
thiopental, 75 mg/kg. After the procedures
or after entry in the study the animals were
kept in individual cages with free access to
water and ration. For the study of gastric
compliance, the animal was anesthetized with
a mixture of 85 mg/kg ketamine + 10 mg/kg
xylazine administered ip.
Dp (Sigma, St. Louis, MO, USA), AA
(Sigma) and bac (Sigma) were diluted with
sterile physiological saline as a vehicle at the
time of the study. The doses, in µmol, ap-
plied iv and icv were established on the basis
of previous studies with Dp (1,2). GE and
stomach compliance were determined after
a 24-h fast, although the animals continued
to receive water ad libitum up to 30 min
before the studies.
In all the studies described below, except
for the time-response effect, GE was as-
sessed in each animal 10 min after the iv or
icv administration of the drug or vehicle. For
the comparison of the effect of iv adminis-
tration on GE, 240 µmol/kg Dp or AA (80
and 48.77 mg/kg, respectively) or vehicle
(control) were administered through a cau-
dal vein. In the study of the icv effect, a
stainless steel cannula (22 G) was implanted
into the right lateral ventricle of each animal
eight days before the experiment using pre-
viously established coordinates (1). An in-
ternal microinjection cannula (28 G) con-
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nected by polyethylene tubing to a 25-µL
Hamilton syringe was used for icv injection.
A 10-µL volume of vehicle (control) or Dp
solution (4 µmol = 1333.2 µg) or AA solu-
tion (4 µmol = 812.8 µg) was used.
In the dose-response study, 30 (6.09 mg/
kg), 60 (12.19 mg/kg), 120 (24.38 mg/kg),
and 240 µmol/kg (48.77 mg/kg) AA were
administered iv. Control animals received
vehicle by the same route.
For the evaluation of the participation of
the vagus nerve, the rats were submitted to
subdiaphragmatic section of the ventral and
dorsal branches of the vagus (VgX group)
two weeks before the experiment. The sham
group consisted of rats submitted to surgery
without sectioning of the vagus. Each of
these groups was divided into two groups
receiving vehicle (control) and AA at the
dose of 240 µmol/kg (48.77 mg/kg) iv, re-
spectively.
The participation of GABAB receptors in
the CNS in the effect of AA on GE was
assessed by using icv injection of 10 µL ve-
hicle (bac0), or of a solution containing 2 µg
baclofen (bac2), followed by iv vehicle (con-
trol), or an AA solution of 240 µmol/kg. For
the study of the time-response effect, 240
µmol/kg (48.77 mg/kg) AA or vehicle were
injected iv and GE was determined 10, 30, 60,
120, and 240 min after administration.
GE was evaluated indirectly in awake ani-
mals by determining percent gastric retention
(GR) of 2 mL/kg of a saline test meal labeled
with phenol red at the concentration of 60 µg/
mL, 10 min after administration by gavage
using a standardized technique (12). The ab-
sorbance of the dye was read with a spectro-
photometer at 560-nm wavelength.
Compliance was measured by the tech-
nique described by Bustorff-Silva et al. (4).
After a 24-h fast, the animals were anesthe-
tized and submitted to tracheotomy, abdomi-
nal incision, lavage of the stomach after
pylorus ligation, and fixation in the distal
esophagus of an orogastric polyethylene tube
(2-mm inner diameter and 25 cm in length)
filled with saline and connected through a
three-way stop cock to an infusion pump
(model LF 2001; Lifemed, São Paulo, SP,
Brazil) and to a monitor for pressure record-
ing (Biomonitor 7; BESE, São Paulo, SP,
Brazil). Thirty minutes after these proce-
dures, each animal received an iv infusion
through the external jugular of vehicle (con-
trol group), or of Dp or AA at the dose of 240
µmol/kg. Ten minutes after iv application,
saline solution at 37ºC was infused into the
stomach at the rate of 2 mL 100 g weight-1
min-1 intermittently every 20 s at 1-min in-
tervals. The infusion was stopped every 20 s
(1/3 of the volume) and the system was
equilibrated for 50 s, with recording of intra-
gastric pressure (IGP). IGP values corre-
sponding to 1/3 and 2/3 of the volume and to
the total volume were recorded and the pro-
cedure was repeated two more times at 30-
min intervals. The results for each animal
corresponded to the mean of the three IGP
measurements at each point. Volume-pres-
sure curves were constructed to estimate
gastric compliance, which was calculated by
the following formula: compliance (mL/
mmHg) = V1 -V0/P1 - P0, where V0 = initial
volume and V1 = final volume, P0 = initial
IGP and P1 = final IGP.
At the end of the experiments all animals
were sacrificed and 10 µL 1% Evans blue
solution was injected by the same route in
those that had received icv injection. The
brain was removed and fixed in 10% forma-
lin for 24 h. After fixation, coronal sections
of the brain were obtained and icv injection
was confirmed when the dye was seen in the
4th ventricle.
Data are reported as mean ± SEM and were
analyzed statistically by ANOVA followed by
the Tukey test, when necessary, for pair com-
parisons. The α value was set at 5%.
Results
Data regarding the iv effect of Dp and
AA are presented in Figure 1A. Dp and AA
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istration of AA.
Figure 2 presents the volume-pressure
curves for the rats treated iv with Dp and AA
and for the saline controls. The pressures
obtained with drug application in the three
measurements were significantly lower than
control. In addition, gastric compliance was
significantly greater in the animals treated
with Dp (mean ± SEM, 0.26 ± 0.009 mL/
mmHg, N = 11) and AA (0.24 ± 0.012 mL/
mmHg, N = 10) compared to the saline
control (0.19 ± 0.009 mL/mmHg, N = 10).
The two drugs did not differ from one an-
other regarding the effects on the volume-
pressure curves and on gastric compliance.
There was a significant increase in GR in
the animals treated iv with AA at the doses of
60, 120, and 240 µmol/kg compared to con-
trol (Figure 3A), with a positive and signifi-
cant correlation (r = 0.92). We also observed
that, at the dose of 240 µmol/kg, the GR of
the saline test meal was marked and signifi-
cant at 10, 30, and 60 min compared to the
respective controls, with a reduction at 120
min, and being no longer significant at 240
min (Figure 3B).
VgX reduced the effect of AA on GR,
although a significant difference continued
to be present compared to the animals sub-
mitted to the same surgical procedure and
treated with vehicle (Figure 4A). There was
a significant reduction of GR in VgX ani-
mals treated with AA compared to the sham
group also treated with the drug (VgX + AA
vs sham + AA) and nonsignificant reduction
of GR between the control groups (VgX +
control vs sham + control). This reduction
was more intense, about 2.5-fold, among the
animals treated with AA (a 56% reduction of
mean GR) than in the control groups (a
22.3% reduction of mean GR).
The results regarding the effect of the icv
administration of bac on the effect of AA are
illustrated in Figure 4B. The bac0 AA group
had a significantly greater GR compared to
the bac0 control group. On the other hand,
the GR of the bac2 AA group did not differ
Figure 1. Gastric retention of a
saline test meal 10 min after ad-
ministration to rats by gavage.
A, Ten minutes before the evalu-
ation of gastric retention, the ani-
mals received iv administration
of vehicle (C), 240 µmol/kg
dipyrone (Dp, 80 mg/kg) or 4-
aminoantipyrine (AA, 48.8 mg/
kg). B, A metal cannula was im-
planted into the right lateral ven-
tricle of all rats 8 days before the
experiment. The animals re-
ceived icv administration of 10
µL vehicle (C) or an equal vol-
ume of a solution containing 4
µmol (1.33 mg) Dp or 4 µmol
(813 µg) AA. Gastric retention
was evaluated 10 min after the
icv injections. Data are reported
as mean ± SEM for 10 animals
per group. *P < 0.05 compared
to control (Tukey test).
Figure 2. Volume-pressure
curves after intragastric instilla-
tion of increasing saline volumes
in anesthetized rats injected with
dipyrone (Dp) iv or 4-aminoanti-
pyrine (AA) at the dose of 240
µmol/kg body weight or with ve-
hicle (saline). Data are reported
as mean ± SEM; Dp (N = 11),
AA (N = 10), saline (N = 10); *P
< 0.05 compared to the saline
control (Tukey test).
caused significantly greater GR compared to
control. The increase in GR was more marked
in the AA group (mean ± SEM, 64.4 ± 2.5%)
but was not significant compared to Dp (54.3
± 3.8%). A comparative evaluation of the icv
effect of Dp and AA is presented in Figure
1B. A significant increase in GR was ob-
served in the Dp group compared to control,
a fact that was not observed after the admin-
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significantly from control (bac2 control).
Bac administered icv significantly reduced
GR in the animals treated iv with AA (bac0
AA vs bac2 AA), as also observed in the
control group treated with iv saline (bac0
control vs bac2 control). However, the re-
duction was 2-fold greater among those
treated with AA (a 56.4% reduction of mean
GR) than among those that received saline (a
24.5% reduction of mean GR).
Discussion
AA and Dp administered iv at equimolar
doses caused a similar delay of GE of the
same test liquid meal (Figure 1A). AA is one
of the Dp metabolites that reaches 60% of
plasma concentration in the CNS after the
administration of this pro-drug (13). In a
previous paper (1), we demonstrated that icv
Dp at a dose 16-fold higher than that admin-
istered iv delays liquid GE, but this phenom-
enon was not observed with AA. These re-
sults were confirmed in the present study
(Figure 1B).
Intravenous administration at equimolar
doses of the two phenylpyrazolone deriva-
tives to anesthetized animals induced an in-
crease in gastric compliance nearly equal. Since
gastric compliance reflects accommodation of
the proximal stomach (fundus and part of the
body), an area that is also responsible for GE
of liquid (3), it is possible that the effect of
these derivatives on GE or on part of it is the
consequence of an increased relaxation of this
functional part of the stomach.
The effect of AA on GE was dose de-
pendent but was more intense and uniform
during the first hour after administration
(Figure 3A and B). In some aspects the
results differed from those previously re-
ported by us for Dp (1), i.e., at the dose of 60
µmol/kg the effect of AA was significant
compared to control, and 120 min after ad-
ministration of the AA dose of 240 µmol/kg
the difference from control was maintained
even though there was a reduction of the
Figure 3. Gastric retention of a saline test meal 10 min after administration to rats by
gavage. A, Ten minutes before the evaluation of gastric retention, the animals received
vehicle (C) or 30, 60, 120, and 240 µmol/kg 4-aminoantipyrine (AA) iv. B, Ten, 30, 60, 120,
and 240 min before the evaluation of gastric retention, the animals received vehicle (C) or
240 µmol/kg AA iv. Data are reported as mean ± SEM for 5 animals per group. *P < 0.05
compared to control (Tukey test).
Figure 4. Gastric retention of a saline test meal 10 min after administration to rats by
gavage. A, Two weeks before the experiment the animals were submitted to sham surgery
or to subdiaphragmatic vagotomy (VgX). Ten minutes before the evaluation of gastric
retention, the rats in each group received vehicle (C) or 4-aminoantipyrine (AA), 240 µmol/
kg iv. B, A metal cannula was implanted into the right lateral ventricle of all rats 8 days
before the experiment. The animals received an injection of 10 µL vehicle (bac0) or an
equal volume of a solution containing 2 µg baclofen (bac2) icv injected over a period of 30 s,
and vehicle (C) or a solution of AA, 240 µmol/kg (AA, 48.77 mg/kg) iv. Gastric retention was
evaluated 10 min after the iv injections. Data are reported as mean ± SEM for 10 animals
per group. *P < 0.05 compared to control (Tukey test).
effect of the drug.
There is evidence of vagus involvement
in the delay of GE induced by AA since
vagotomy reduced the effect of the drug,
which was 2.5-fold greater than that ob-
served in the animals that did not receive the
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drug (Figure 4A). However, the difference
continued to be significant compared to con-
trol. In a previous study, we observed that
vagotomy fully abolished the effect of Dp
(1). On this basis, it is not possible to exclude
the apparently discrete action of AA, inde-
pendent of the vagus nerve, on smooth muscle
fibers and/or on the enteric nervous system
of the stomach and duodenum, about which
no information is available. The in vitro
effect of Dp using preparations of intestinal
segments (gastric musculature, jejunum and
ileum) and of the ureter was minimal or
absent (14-17).
Additionally, it was demonstrated that
the delay in GE determined by AA was
blocked by the administration of bac in the
CNS (Figure 4B), as also reported for Dp
(2). In the CNS, bac activates GABAB recep-
tors, promoting modulation of neurotrans-
mission by hyperpolarization of the post-
synaptic membranes or inhibition of neuro-
transmitter release at the presynaptic end-
ings (18). There is evidence that GABA
participates in the control of gastric motility
at the level of the nucleus tractus solitarii, a
CNS structure that receives afferent infor-
mation through the vagus nerve (19-21).
Although the mechanisms by which Dp
and AA cause a delay in GE are unknown, it
is possible to speculate that the phenomenon
is due to the effect of a disequilibrium be-
tween the efferent stimulatory/inhibitory sys-
tem of the vagus on gastric tonus, with origin
in the CNS. Supporting this is the fact that
vagotomy and the iv activation of GABAB
receptors reduced the delay in GE caused by
Dp (1,2) and by AA. Additionally, since AA
had no effect when administered icv, it is
possible that the stimulation of the delay in
GE produced by this metabolite reaches the
CNS through an afferent pathway.
This hypothesis may be relevant also for
antipyrine, another phenylpyrazolone deriva-
tive studied in our laboratory (22). In that
study antipyrine showed some similarities to
AA such as producing no effect when ad-
ministered directly into the CNS and a re-
duced effect after vagotomy and after bac
administration. However, antipyrine showed
one difference compared to AA, i.e., the
effect was more intense at 10 min after the
administration of antipyrine, possibly due to
the fact that the pharmacokinetics of antipy-
rine differs from that of AA (22).
On the other hand, it is reasonable to
assume that the more prolonged effect of
AA, which was not fully abolished by va-
gotomy, is due to the use of a higher iv dose
in relation to the amount of this metabolite,
which would be generated slowly in the
internal medium from Dp. On this basis, Dp
administered iv would produce a delay in
GE not only through a possible direct action
on the CNS (1), but also by the peripheral
action of at least one of its metabolites (AA).
This hypothesis, plus the possible participa-
tion of other metabolites, make it question-
able that the iv effect of Dp on GE would
occur by a direct action on the CNS, as
previously proposed (1), actually function-
ing as a pro-drug.
Our data suggest that AA and Dp admin-
istered iv increase gastric compliance, and
AA, with the participation of the vagus nerve,
induces delayed GE of liquid in rats through
a pathway that does not involve a direct
action of the drug on the CNS.
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